Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives

References

• MartinonFBurnsKTschoppJThe inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-betaMol Cell200210241742612191486
   PubMed Web of Science ®Google Scholar
• LamkanfiMEmerging inflammasome effector mechanismsNat Rev Immunol201111321322021350580
   PubMed Web of Science ®Google Scholar
• SchroderKTschoppJThe inflammasomesCell2010140682183220303873
   PubMed Web of Science ®Google Scholar
• CridlandJACurleyEZWykesMNThe mammalian PYHIN gene family: phylogeny, evolution and expressionBMC Evol Biol20121214022871040
   PubMed Web of Science ®Google Scholar
• MinkiewiczJde Rivero VaccariJPKeaneRWHuman astrocytes express a novel NLRP2 inflammasomeGlia20136171113112123625868
   PubMed Web of Science ®Google Scholar
• FaustinBLartigueLBrueyJMReconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activationMol Cell200725571372417349957
   PubMed Web of Science ®Google Scholar
• MiaoEAAlpuche-ArandaCMDorsMCytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via IpafNat Immunol20067656957516648853
   PubMed Web of Science ®Google Scholar
• FranchiLAmerABody-MalapelMCytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophagesNat Immunol20067657658216648852
   PubMed Web of Science ®Google Scholar
• HornungVAblasserACharrel-DennisMAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCNature2009458723751451819158675
   PubMed Web of Science ®Google Scholar
• GrenierJMWangLManjiGAFunctional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1FEBS Lett20025301–3737812387869
   PubMed Web of Science ®Google Scholar
• WangLManjiGAGrenierJMPYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processingJ Biol Chem200227733298742988012019269
   PubMed Web of Science ®Google Scholar
• RathinamVAVanajaSKWaggonerLTRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteriaCell2012150360661922819539
   PubMed Web of Science ®Google Scholar
• AllenICScullMAMooreCBThe NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNAImmunity200930455656519362020
   PubMed Web of Science ®Google Scholar
• ThomasPGDashPAldridgeJRJrThe intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1Immunity200930456657519362023
   PubMed Web of Science ®Google Scholar
• GrossOPoeckHBscheiderMSyk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defenceNature2009459724543343619339971
   PubMed Web of Science ®Google Scholar
• MariathasanSWeissDSNewtonKCryopyrin activates the inflammasome in response to toxins and ATPNature2006440708122823216407890
   PubMed Web of Science ®Google Scholar
• MartinonFPetrilliVMayorATardivelATschoppJGout-associated uric acid crystals activate the NALP3 inflammasomeNature2006440708123724116407889
   PubMed Web of Science ®Google Scholar
• HalleAHornungVPetzoldGCThe NALP3 inflammasome is involved in the innate immune response to amyloid-betaNat Immunol20089885786518604209
   PubMed Web of Science ®Google Scholar
• MastersSLDunneASubramanianSLActivation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetesNat Immunol2010111089790420835230
   PubMed Web of Science ®Google Scholar
• DoyleSLCampbellMOzakiENLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen componentsNat Med201218579179822484808
   PubMed Web of Science ®Google Scholar
• KummerJABroekhuizenREverettHInflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory responseJ Histochem Cytochem200755544345217164409
   PubMed Web of Science ®Google Scholar
• DuncanJABergstralhDTWangYCryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signalingProc Natl Acad Sci U S A2007104198041804617483456
   PubMed Web of Science ®Google Scholar
• BauernfeindFBartokERiegerAFranchiLNunezGHornungVCutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasomeJ Immunol2011187261361721677136
   PubMed Web of Science ®Google Scholar
• JulianaCFernandes-AlnemriTKangSFariasAQinFAlnemriESNon-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activationJ Biol Chem201228743366173662222948162
   PubMed Web of Science ®Google Scholar
• Lopez-CastejonGLuheshiNMCompanVDeubiquitinases regulate the activity of caspase-1 and interleukin-1beta secretion via assembly of the inflammasomeJ Biol Chem201328842721273323209292
   PubMed Web of Science ®Google Scholar
• PetrilliVPapinSDostertCMayorAMartinonFTschoppJActivation of the NALP3 inflammasome is triggered by low intracellular potassium concentrationCell Death Differ20071491583158917599094
   PubMed Web of Science ®Google Scholar
• KannegantiTDLamkanfiMKimYGPannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signalingImmunity200726443344317433728
   PubMed Web of Science ®Google Scholar
• PelegrinPSurprenantAPannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptorEMBO J200625215071508217036048
   PubMed Web of Science ®Google Scholar
• HornungVBauernfeindFHalleASilica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNat Immunol20089884785618604214
   PubMed Web of Science ®Google Scholar
• ZhouRTardivelAThorensBChoiITschoppJThioredoxin-interacting protein links oxidative stress to inflammasome activationNat Immunol201011213614020023662
   PubMed Web of Science ®Google Scholar
• ZhouRYazdiASMenuPTschoppJA role for mitochondria in NLRP3 inflammasome activationNature2011469732922122521124315
   PubMed Web of Science ®Google Scholar
• NakahiraKHaspelJARathinamVAAutophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasomeNat Immunol201112322223021151103
   PubMed Web of Science ®Google Scholar
• CompanVBaroja-MazoALopez-CastejonGCell volume regulation modulates NLRP3 inflammasome activationImmunity201237348750022981536
   PubMed Web of Science ®Google Scholar
• GongYNWangXWangJChemical probing reveals insights into the signaling mechanism of inflammasome activationCell Res201020121289130520856264
   PubMed Web of Science ®Google Scholar
• FranceschiCBonafeMValensinSInflamm-aging. An evolutionary perspective on immunosenescenceAnn N Y Acad Sci200090824425410911963
   PubMed Web of Science ®Google Scholar
• DuewellPKonoHRaynerKJNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature201046472931357136120428172
   PubMed Web of Science ®Google Scholar
• EganDFShackelfordDBMihaylovaMMPhosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagyScience2011331601645646121205641
   PubMed Web of Science ®Google Scholar
• MathewsRJRobinsonJIBattellinoMEvidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentAnn Rheum Dis20147361202121023687262
   PubMed Web of Science ®Google Scholar
• Vande WalleLVan OpdenboschNJacquesPNegative regulation of the NLRP3 inflammasome by A20 protects against arthritisNature20145127512697325043000
   PubMed Web of Science ®Google Scholar
• HugotJPChamaillardMZoualiHAssociation of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s diseaseNature2001411683759960311385576
   PubMed Web of Science ®Google Scholar
• OguraYBonenDKInoharaNA frameshift mutation in NOD2 associated with susceptibility to Crohn’s diseaseNature2001411683760360611385577
   PubMed Web of Science ®Google Scholar
• AguileraMDarbyTMelgarSThe complex role of inflammasomes in the pathogenesis of inflammatory bowel diseases – lessons learned from experimental modelsCytokine Growth Factor Rev4182014 Epub ahead of print
   Web of Science ®Google Scholar
• KanaiTWatanabeMOkazawaAMacrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn’s diseaseGastroenterology2001121487588811606501
   PubMed Web of Science ®Google Scholar
• ZakiMHBoydKLVogelPKastanMBLamkanfiMKannegantiTDThe NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitisImmunity201032337939120303296
   PubMed Web of Science ®Google Scholar
• VillaniACLemireMFortinGCommon variants in the NLRP3 region contribute to Crohn’s disease susceptibilityNat Genet2009411717619098911
   PubMed Web of Science ®Google Scholar
• SiegmundBInterleukin-18 in intestinal inflammation: friend and foe?Immunity201032330030220346770
   PubMed Web of Science ®Google Scholar
• KolbRLiuGHJanowskiAMSutterwalaFSZhangWInflammasomes in cancer: a double-edged swordProtein Cell201451122024474192
   PubMed Web of Science ®Google Scholar
• WinterRNRheeJGKyprianouNCaspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiationAnticancer Res2004243a1377138615274298
   PubMed Web of Science ®Google Scholar
• WinterRNKramerABorkowskiAKyprianouNLoss of caspase-1 and caspase-3 protein expression in human prostate cancerCancer Res20016131227123211221855
   PubMed Web of Science ®Google Scholar
• AllenICTeKippeEMWoodfordRMThe NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancerJ Exp Med201020751045105620385749
   PubMed Web of Science ®Google Scholar
• DaoTMehalWZCrispeINIL-18 augments perforin-dependent cytotoxicity of liver NK-T cellsJ Immunol19981615221722229725214
   PubMed Web of Science ®Google Scholar
• MicallefMJYoshidaKKawaiSIn vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascitesCancer Immunol Immunother19974363613679067408
   PubMed Web of Science ®Google Scholar
• OsakiTPeronJMCaiQIFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effectsJ Immunol19981604174217499469432
   PubMed Web of Science ®Google Scholar
• TermeMUllrichEAymericLIL-18 induces PD-1-dependent immunosuppression in cancerCancer Res201171165393539921724589
   PubMed Web of Science ®Google Scholar
• LustJALacyMQZeldenrustSRInduction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative componentMayo Clin Proc200984211412219181644
   PubMed Web of Science ®Google Scholar
• OzkuredeVUFranchiLImmunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromesClin Exp Immunol2012167338239022288581
   PubMed Web of Science ®Google Scholar
• MartinonFTschoppJInflammatory caspases and inflammasomes: master switches of inflammationCell Death Differ2007141102216977329
   PubMed Web of Science ®Google Scholar
• FedericiSCaorsiRGattornoMThe autoinflammatory diseasesSwiss Med Wkly2012142w1360222714396
   PubMed Web of Science ®Google Scholar
• AgannaEMartinonFHawkinsPNAssociation of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosisArthritis Rheum20024692445245212355493
   PubMed Web of Science ®Google Scholar
• HoffmanHMRosengrenSBoyleDLPrevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonistLancet200436494471779178515541451
   PubMed Web of Science ®Google Scholar
• NevenBMarvilletITerradaCLong-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndromeArthritis Rheum201062125826720039428
   PubMed Web of Science ®Google Scholar
• LeporeLPaloniGCaorsiRFollow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with anakinraJ Pediatr20101572310315.e31120472245
   PubMed Web of Science ®Google Scholar
• Goldbach-ManskyRDaileyNJCannaSWNeonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J MedA20063556581592
   Google Scholar
• TanMSYuJTJiangTZhuXCTanLThe NLRP3 inflammasome in Alzheimer’s diseaseMol Neurobiol201348387588223686772
   PubMed Web of Science ®Google Scholar
• MollMKuemmerle-DeschnerJBInflammasome and cytokine blocking strategies in autoinflammatory disordersClin Immunol2013147324227523697917
   PubMed Web of Science ®Google Scholar
• ZhangHAnti-IL-1beta therapiesRecent Pat DNA Gene Seq20115212613521762108
   PubMedGoogle Scholar
• Kone-PautIGaleottiCAnakinra for cryopyrin-associated periodic syndromeExpert Rev Clin Immunol201410171824308832
   PubMed Web of Science ®Google Scholar
• DinarelloCASimonAvan der MeerJWTreating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNat Rev Drug Discov201211863365222850787
   PubMed Web of Science ®Google Scholar
• AshcroftFMATP-sensitive potassium channelopathies: focus on insulin secretionJ Clin Invest200511582047205816075046
   PubMed Web of Science ®Google Scholar
• LamkanfiMMuellerJLVitariACGlyburide inhibits the cryopyrin/Nalp3 inflammasomeJ Cell Biol20091871617019805629
   PubMed Web of Science ®Google Scholar
• MarchettiCChojnackiJToldoSA novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouseJ Cardiovasc Pharmacol201463431632224336017
   PubMed Web of Science ®Google Scholar
• HeinrichMRoblesMWestJEOrtiz de MontellanoBRRodriguezEEthnopharmacology of Mexican asteraceae (Compositae)Annu Rev Pharmacol Toxicol1998385395659597165
   PubMed Web of Science ®Google Scholar
• JulianaCFernandes-AlnemriTWuJAnti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasomeJ Biol Chem2010285139792980220093358
   PubMed Web of Science ®Google Scholar
• CollRCO’NeillLAThe cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomesPLoS One2011612e2953922216309
   PubMed Web of Science ®Google Scholar
• KeystoneECWangMMLaytonMHollisSMcInnesIBClinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazineAnn Rheum Dis201271101630163522966146
   PubMed Web of Science ®Google Scholar
• StockTCBloomBJWeiNEfficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexateJ Rheumatol201239472072722382341
   PubMed Web of Science ®Google Scholar
• AliZLaurijssensBOstenfeldTPharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjectsBr J Clin Pharmacol201375119720722568863
   PubMed Web of Science ®Google Scholar
• ArulkumaranNUnwinRJTamFWA potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseasesExpert Opin Investig Drugs2011207897915
   PubMed Web of Science ®Google Scholar
• DinarelloCAImmunological and inflammatory functions of the interleukin-1 familyAnnu Rev Immunol20092751955019302047
   PubMed Web of Science ®Google Scholar
• NetaRDouchesSOppenheimJJInterleukin 1 is a radioprotectorJ Immunol19861367248324853512714
   PubMed Web of Science ®Google Scholar
• HancockSLChungRTCoxRSKallmanRFInterleukin 1 beta initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiationCancer Res1991519228022852015592
   PubMed Web of Science ®Google Scholar
• BergmannMBarnesPJNewtonRMolecular regulation of granulocyte macrophage colony-stimulating factor in human lung epithelial cells by interleukin (IL)-1beta, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanismsAm J Respir Cell Mol Biol200022558258910783130
   PubMed Web of Science ®Google Scholar
• BagbyGCJrInterleukin-1 and hematopoiesisBlood Rev1989331521612529007
   PubMed Web of Science ®Google Scholar
• CrownJJakubowskiAGabriloveJInterleukin-1: biological effects in human hematopoiesisLeuk Lymphoma1993964334408339049
   PubMed Web of Science ®Google Scholar
• CrownJJakubowskiAKemenyNA phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancerBlood1991786142014271884014
   PubMed Web of Science ®Google Scholar
• NemunaitisJAppelbaumFRLillebyKPhase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemiaBlood19948312347334798204876
   PubMed Web of Science ®Google Scholar
• KitamuraKTakahashiTYamaguchiTImmunochemical characterization of the antigen recognized by the murine monoclonal antibody A7 against human colorectal cancerTohoku J Exp Med1989157283932711385
   PubMed Web of Science ®Google Scholar
• PurenAJFantuzziGDinarelloCAGene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cellsProc Natl Acad Sci U S A19999652256226110051628
   PubMed Web of Science ®Google Scholar
• NeteaMGJoostenLALewisEDeficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistanceNat Med200612665065616732281
   PubMed Web of Science ®Google Scholar
• GattiSBeckJFantuzziGBartfaiTDinarelloCAEffect of interleukin-18 on mouse core body temperatureAm J Physiol Regul Integr Comp Physiol20022823R702R70911832389
   PubMed Web of Science ®Google Scholar
• RobertsonMJKirkwoodJMLoganTFA dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancerClin Cancer Res200814113462346918519778
   PubMed Web of Science ®Google Scholar
• SimpkinsFFloresAChuCChemoimmunotherapy using PEGylated liposomal dDoxorubicin and interleukin-18 in recurrent ovarian cancer: a pphase I dose-escalation studyCancer Immunol Res20131316817824777679
   PubMed Web of Science ®Google Scholar
• TarhiniAAMillwardMMainwaringPA phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanomaCancer2009115485986819140204
   PubMed Web of Science ®Google Scholar
• DinarelloCANovickDKimSKaplanskiGInterleukin-18 and IL-18 binding proteinFront Immunol2013428924115947
   PubMed Web of Science ®Google Scholar
• RobertsonMJMierJWLoganTClinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerClin Cancer Res20061214 Pt 14265427316857801
   PubMed Web of Science ®Google Scholar
• HirotaSANgJLuengANLRP3 inflammasome plays a key role in the regulation of intestinal homeostasisInflamm Bowel Dis20111761359137220872834
   PubMed Web of Science ®Google Scholar
• ElinavEStrowigTKauALNLRP6 inflammasome regulates colonic microbial ecology and risk for colitisCell2011145574575721565393
   PubMed Web of Science ®Google Scholar
• ChenCJKonoHGolenbockDReedGAkiraSRockKLIdentification of a key pathway required for the sterile inflammatory response triggered by dying cellsNat Med200713785185617572686
   PubMed Web of Science ®Google Scholar
• Dupaul-ChicoineJYeretssianGDoironKControl of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspasesImmunity201032336737820226691
   PubMed Web of Science ®Google Scholar
• TaralloVHiranoYGelfandBDDICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88Cell2012149484785922541070
   PubMed Web of Science ®Google Scholar
• TsengWATheinTKinnunenKNLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degenerationInvest Ophthalmol Vis Sci201354111012023221073
   PubMed Web of Science ®Google Scholar
• MarnerosAGNLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degenerationCell Rep20134594595824012762
   PubMed Web of Science ®Google Scholar
• DoyleSLOzakiEBrennanKIL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSci Transl Med20146230230ra244
   Web of Science ®Google Scholar
• ShenJChoyDFYoshidaTInterleukin-18 has antipermeablity and antiangiogenic activities in the eye; reciprocal suppression with VEGFJ Cell Physiol2014229897498324515951
   PubMed Web of Science ®Google Scholar
• BoydenEDDietrichWFNalp1b controls mouse macrophage susceptibility to anthrax lethal toxinNat Genet200638224024416429160
   PubMed Web of Science ®Google Scholar
• AgostiniLMartinonFBurnsKMcDermottMFHawkinsPNTschoppJNALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorderImmunity200420331932515030775
   PubMed Web of Science ®Google Scholar
• KempsterSLBeltekiGForheadAJDevelopmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestineAm J Physiol Gastrointest Liver Physiol20113002G253G26321088234
   PubMed Web of Science ®Google Scholar
• KhareSDorfleutnerABryanNBAn NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophagesImmunity201236346447622361007
   PubMed Web of Science ®Google Scholar
• VladimerGIWengDPaquetteSWThe NLRP12 inflammasome recognizes Yersinia pestisImmunity20123719610722840842
   PubMed Web of Science ®Google Scholar
• PoyetJLSrinivasulaSMTnaniMRazmaraMFernandes-AlnemriTAlnemriESIdentification of Ipaf, a human caspase-1-activating protein related to Apaf-1J Biol Chem200127630283092831311390368
   PubMed Web of Science ®Google Scholar
• JesusAASilvaCASegundoGRPhenotype-genotype analysis of cryopyrin-associated periodic syndromes (CAPS): description of a rare non-exon 3 and a novel CIAS1 missense mutationJ Clin Immunol200828213413818080732
   PubMed Web of Science ®Google Scholar
• StojanovSWeissMLohsePBelohradskyBHA novel CIAS1 mutation and plasma/cerebrospinal fluid cytokine profile in a German patient with neonatal-onset multisystem inflammatory disease responsive to methotrexate therapyPediatrics20041141e124e12715231984
   PubMed Web of Science ®Google Scholar
• VlagopoulosTTownleyRVillacorteGFamilial cold urticariaAnn Allergy197534636636949161
   PubMedGoogle Scholar
• HoffmanHMMuellerJLBroideDHWandererAAKolodnerRDMutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndromeNat Genet200129330130511687797
   PubMed Web of Science ®Google Scholar
• AksentijevichID PutnamCRemmersEFThe clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin modelArthritis Rheum20075641273128517393462
   PubMed Web of Science ®Google Scholar
• DodéCLe DûNCuissetLNew mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromesAm J Hum Genet20027061498150611992256
   PubMed Web of Science ®Google Scholar
• FeldmannJPrieurAMQuartierPChronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytesAm J Hum Genet200271119820312032915
   PubMed Web of Science ®Google Scholar
• CaroliFPontilloAD’OsualdoAClinical and genetic characterization of Italian patients affected by CINCA syndromeRheumatology (Oxford)200746347347816920754
   PubMed Web of Science ®Google Scholar
• MiraultTLaunayDCuissetLRecovery from deafness in a patient with Muckle-Wells syndrome treated with anakinraArthritis Rheum20065451697170016646042
   PubMed Web of Science ®Google Scholar
• BoschanCWittOLohsePFoeldvariIZappelHSchweigererLNeonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatmentAm J Med Genet A2006140888388616532456
   PubMed Web of Science ®Google Scholar
• HoffmanHMGregorySGMuellerJLFine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353PHum Genet2003112220921612522564
   PubMed Web of Science ®Google Scholar
• KoikeRKubotaTHaraYA case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin)Mod Rheumatol200717649649918084703
   PubMedGoogle Scholar
• ZeftABohnsackJFCryopyrin-associated autoinflammatory syndrome: a new mutationAnn Rheum Dis200766684384417513575
   PubMed Web of Science ®Google Scholar
• ShepardMKCold hypersensitivityBirth Defects Orig Artic Ser1971783525173311
   PubMedGoogle Scholar
• DalgicBEgritasOSariSCuissetLA variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinraPediatr Nephrol20072291391139417486372
   PubMed Web of Science ®Google Scholar
• ArosteguiJIAldeaAModestoCClinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 geneArthritis Rheum200450124045405015593220
   PubMed Web of Science ®Google Scholar
• StackJHBeaumontKLarsenPDIL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patientsJ Immunol200517542630263416081838
   PubMed Web of Science ®Google Scholar
• SaitoMNishikomoriRKambeNDisease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patientsBlood200811142132214118063752
   PubMed Web of Science ®Google Scholar
• AksentijevichINowakMMallahMDe novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseasesArthritis Rheum200246123340334812483741
   PubMed Web of Science ®Google Scholar
• WandererAAAn ‘allergy’ to coldHosp Pract1979146136137447320
   PubMed Web of Science ®Google Scholar
• MatsubayashiTSugiuraHAraiTOh-IshiTInamoYAnakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 geneActa Paediatr200695224624916449034
   PubMed Web of Science ®Google Scholar
• OhnishiHTeramotoTIwataHCharacterization of NLRP3 variants in Japanese cryopyrin-associated periodic syndrome patientsJ Clin Immunol201232222122922193915
   PubMed Web of Science ®Google Scholar
• FrenkelJvan KempenMJKuisWvan AmstelHKVariant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1Arthritis Rheum20045082719272015334500
   PubMed Web of Science ®Google Scholar